Cover Image

The impact of CYP2C19 genotype on phenoconversion by concomitant medication

Introduction: Pharmacogenetics-informed drug prescribing is increasingly applied in clinical practice. Typically, drug metabolizing phenotypes are determined based on genetic test results, whereupon dosage or drugs are adjusted. Drug-drug-interactions (DDIs) caused by concomitant medication can howe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura M. de Jong (Author), Soukayna Boussallami (Author), Elena Sánchez-López (Author), Martin Giera (Author), Maarten E. Tushuizen (Author), Menno Hoekstra (Author), Lukas J. A. C. Hawinkels (Author), Robert Rissmann (Author), Jesse J. Swen (Author), Martijn L. Manson (Author)
Format:	Book
Published:	Frontiers Media S.A., 2023-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Case report: Therapeutic drug monitoring and CYP2D6 phenoconversion in a protracted paroxetine intoxication
by: Alena Damborská, et al.
Published: (2024)

Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism
by: Malavika Deodhar, et al.
Published: (2021)

Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines
by: Lisanne E. N. Manson, et al.
Published: (2020)

Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
by: Sylvia D. Klomp, et al.
Published: (2024)

Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne
by: Diane M. Thiboutot, et al.
Published: (2023)

Editorial: Congenital anomalies: State of the art and the new paradigms for a precision public health approach
by: Babak Khoshnood, et al.
Published: (2022)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020)

Cytomegalovirus seronegativity rate in pregnant women and primary cytomegalovirus infection during pregnancy in rural Germany
by: Hannah Greye, et al.
Published: (2023)

<it>CYP3A4 </it>and <it>CYP3A5 </it>genotyping by Pyrosequencing
by: McLeod Howard L, et al.
Published: (2005)

The Identification of Novel CYP2D6 Variants in US Hmong: Results From Genome Sequencing and Clinical Genotyping
by: Ya Feng Wen, et al.
Published: (2022)

Antimicrobial Peptide Omiganan Enhances Interferon Responses to Endosomal Toll‐Like Receptor Ligands in Human Peripheral Blood Mononuclear Cells
by: Hendrika W. Grievink, et al.
Published: (2020)

Why We Need to Take a Closer Look at Genetic Contributions to CYP3A Activity
by: Qinglian Zhai, et al.
Published: (2022)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
by: Kelly E. Caudle, et al.
Published: (2020)

Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping
by: James C. Coons PharmD, et al.
Published: (2022)

The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
by: Roberta Ferraldeschi, et al.
Published: (2010)

CYP2D7 sequence variation interferes with TaqMan CYP2D6*15 and *35 genotyping
by: Amanda K Riffel, et al.
Published: (2016)

Omiganan Enhances Imiquimod‐Induced Inflammatory Responses in Skin of Healthy Volunteers
by: Tessa Niemeyer‐van der Kolk, et al.
Published: (2020)

CYP1A2 genotype and acute effects of caffeine on resistance exercise, jumping, and sprinting performance
by: Jozo Grgic, et al.
Published: (2020)

Does ethnicity impact CYP2D6 genotype-phenotype relationships?
by: Trine Frederiksen, et al.
Published: (2023)

Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023)

CYP2B6 Genotype‐Dependent Inhibition of CYP1A2 and Induction of CYP2A6 by the Antiretroviral Drug Efavirenz in Healthy Volunteers
by: Ingrid F. Metzger, et al.
Published: (2019)

Interrogation of CYP2D6 Structural Variant Alleles Improves the Correlation Between CYP2D6 Genotype and CYP2D6‐Mediated Metabolic Activity
by: Rachel Dalton, et al.
Published: (2020)

CYP2D6 Genotype-Based Dose Recommendations for Risperidone in Asian People
by: Yuanxia Cui, et al.
Published: (2020)

CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
by: Kuntheavy Ing Lorenzini, et al.
Published: (2021)

Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects.
by: Benjamin Gutjahr, et al.
Published: (2020)

Tacrolimus pharmacokinetics are influenced by CYP3A5, age, and concomitant fluconazole in pediatric kidney transplant patients
by: Alaa Alghamdi, et al.
Published: (2023)

The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers
by: Stefan J. Jodl, et al.
Published: (2024)

Intradermal substance P as a challenge agent in healthy individuals
by: Wouter tenVoorde, et al.
Published: (2023)

Evaluation of Drug-Drug Interactions of Rucaparib and CYP1A2, CYP2C9, CYP2C19, CYP3A, and P‐gp Substrates in Patients With an Advanced Solid Tumor
by: Jim J. Xiao, et al.
Published: (2019)

CYP2D6 genotyping in the daily routine of a psychiatric hospital - pharmacoeconomic evaluation
by: A. A. Kurylev, et al.
Published: (2018)

Relation between CYP2C19 phenotype and genotype in a group of Brazilian volunteers
by: Rafael Linden, et al.
Published: (2009)

The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank
by: Win Lee Edwin Wong, et al.
Published: (2023)

Improved Fracture Healing in Patients with Concomitant Traumatic Brain Injury: Proven or Not?
by: Martijn Hofman, et al.
Published: (2015)

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug-drug-gene interaction network
by: Denise Feick, et al.
Published: (2023)

Cross-sectional study to assess awareness of cytomegalovirus infection among pregnant women in Germany
by: Hannah Greye, et al.
Published: (2022)

Therapeutic Drug Monitoring of Rivastigmine and Donepezil Under Consideration of CYP2D6 Genotype-Dependent Metabolism of Donepezil
by: Ortner M, et al.
Published: (2020)

Effect of co-administered inducer or inhibitor on omeprazole pharmacokinetics based on CYP2C19 genotype
by: Chiaki Kamiya, et al.
Published: (2019)

Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections
by: Sumonrat Chuwongwattana, et al.
Published: (2020)

CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry
by: Espen Molden, et al.
Published: (2021)

Pharmacogenetic testing revisited: 5′nuclease real-time polymerase chain reaction test panels for genotyping CYP2D6 and CYP2C19
by: Larsen JB, et al.
Published: (2017)